Back to Blog
Blog 1 min read June 6, 2026

Personal Trial and Systemic Health

A user participated in a thread regarding a personal trial of GDF-11 and Follistatin (NEUMYO-OA). They reported an interest in the peptide’s potential to improve physical function and systemic health markers beyond simple muscle mass increases.